These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25362972)

  • 1. Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study.
    Belinchón I; Vanaclocha F; de la Cueva-Dobao P; Coto-Segura P; Labandeira J; Herranz P; Taberner R; Juliá B; Cea-Calvo L; Puig L
    J Dermatolog Treat; 2015; 26(4):318-25. PubMed ID: 25362972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
    Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
    Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of the metabolic syndrome in Spanish patients with established cardiovascular disease: CLYDIA study].
    Palma Gámiz JL; Conget Donlo I; Bertomeu González V; Ascaso Gimilio JF; González Juanatey JR; Alegría Ezquerra E; Conthe Gutiérrez P; de la Calle Blasco H; Serrano Ríos M
    Med Clin (Barc); 2007 Mar; 128(11):407-13. PubMed ID: 17394855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
    Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
    Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis.
    Queiro R; Lorenzo A; Tejón P; Pardo E; Coto P; Ballina J
    Int J Rheum Dis; 2019 Feb; 22(2):269-274. PubMed ID: 30398011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing cardiometabolic risk profile in patients with psoriasis.
    Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
    Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and psoriasis: a study in 97 patients.
    Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy.
    Balato A; Caiazzo G; Balato N; Napolitano M;
    G Ital Dermatol Venereol; 2020 Dec; 155(6):733-738. PubMed ID: 30251803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis.
    Bostoen J; Van Praet L; Brochez L; Mielants H; Lambert J
    J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):507-11. PubMed ID: 24772493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk.
    Romero-Pérez D; Belinchón-Romero I; Bellot P; Francés R; Marco F; Ramos-Rincón JM
    Australas J Dermatol; 2019 Nov; 60(4):e304-e310. PubMed ID: 31236937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psoriatic arthritis in France, from infants to the elderly: Findings from two cross-sectional, multicenter studies].
    Galezowski A; Maccari F; Hadj-Rabia S; Sigal ML; Phan A; Lahfa M; Bursztejn AC; Barthélémy H; Boralévi F; Reguiai Z; Chiavérini C; Estève E; Bourrat E; Ruer-Mulard M; Beauchet A; Mahé E;
    Ann Dermatol Venereol; 2018 Jan; 145(1):13-20. PubMed ID: 29146007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome.
    Trovato E; Rubegni P; Prignano F
    Expert Opin Biol Ther; 2022 Dec; 22(12):1443-1448. PubMed ID: 35726639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.